SCHEMBL8565908

SCHEMBL8565908

O=C(O)CN1CCC(N2C(=O)Nc3ccccc3C2c2ccccc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 2/20 0.41
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 2/20 0.38
ALDH1A1 P00352 1/20 0.38
KDM1A O60341 2/20 0.38
CALCRL Q16602 1/20 0.38
OPRL1 P41146 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM3 P20309 1/20 0.37
ATM Q13315 1/20 0.36
CCR5 P51681 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8570205 0.91 MEN1 (0.41) TACR1TP53MAPK1HSD17B10MEN1
SCHEMBL8564525 0.86 CYP1A2 (0.52) TACR1MEN1KMT2AGAAALDH1A1
SCHEMBL8567952 0.86 SLC18A3 (0.49) TACR1KDM1AOPRL1
SCHEMBL6168606 0.86 OPRL1 (0.52) MEN1KMT2AOPRL1CHRM2CHRM3
SCHEMBL8564971 0.86 TACR1 (0.43) TACR1MEN1KMT2AALDH1A1OPRL1
SCHEMBL29445321 0.86 OPRL1 (0.52) MEN1KMT2AOPRL1CHRM2CHRM3
Hydrochloric Acid SCHEMBL8597954 0.85 CYP1A2 (0.51) TACR1MEN1KMT2AGAAALDH1A1
SCHEMBL6168102 0.85 CHRM3 (0.42) TACR1CALCRLOPRL1CHRM3CCR5
SCHEMBL8571012 0.83 CHRM2 (0.49) TP53MEN1KMT2AOPRL1CHRM2
SCHEMBL8571710 0.83 PRCP (0.42) TACR1HSD17B10GAAALDH1A1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626373-B1 Quinazolinone derivatives SUMITOMO PHARMA (JP) 1998-12-23 EP disclosed
US-5556860-A ANTIISCHEMIC AGENTS, BRAIN DISORDERS AND BLOOD METAL CONCENTRATIONS AND KIDNEY DISEASE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1996-09-17 US disclosed
EP-0626373-A1 Quinazolinone derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-30 EP disclosed